Sonova (OTCMKTS:SONVY – Get Free Report) was upgraded by equities researchers at The Goldman Sachs Group to a “strong sell” rating in a research note issued on Tuesday, Zacks.com reports.
Separately, UBS Group upgraded shares of Sonova to a “hold” rating in a research note on Tuesday, August 13th.
Check Out Our Latest Research Report on Sonova
Sonova Trading Down 1.0 %
About Sonova
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Recommended Stories
- Five stocks we like better than Sonova
- 3 Stocks to Consider Buying in October
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- What Does Downgrade Mean in Investing?
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Invest in Small Cap StocksÂ
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.